Early results from LightSight III trial- Dr. Srini Kondapalli

Dr. Srinivas Kondapalli shares some exciting findings in retinal health 🌟 Early results from the LightSight III trial showed photobiomodulation with the Valeda Light Delivery System reduced drusen development in early to intermediate dry age-related macular degeneration (AMD). This could be a game-changer for patients with AMD. Keep your eyes on the horizon for future breakthroughs! 🚀 #retina #AMD #eyecare #valeda